Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
| Level: | Consumer |
|---|---|
| Class: | I |
| Reference: | R2003/1013 |
| Date agreed: | 19 September 2003 |
| Product: | Bioglan Bio Superdophilus Tablets |
| ARTG number: | AUST L 70230 |
| Batch number: | 1809-3 |
| Sponsor: | Australian Pharmaceutical Industries Limited |
| Contact: | 1300 363 032 |
| Reason: | 6 individual bottles of this batch of product subject to quarantine and recall due to their manufacture by Pan Pharmaceuticals Limited have been resupplied to the market in Australin Capital Territory in error. |
A recall notice will appear in the Canberra Times on Friday 19 September 2003.
Classification system:
Class I defects are potentially life-threatening or could cause a serious risk to health.
Class II defects could cause illness or mistreatment, but are not Class I.
Class III defects may not pose a significant hazard to health, but withdrawal may be initiated for other reasons.
Class I & II recalls are considered to be safety related recalls.